Ependymoma Market: Global Industry Analysis and Forecast 2016 - 2024
Persistence Market Research
Ependymoma Market: Global Industry Analysis and Forecast 2016 - 2024
Persistence Market Research
1
Ependymoma Market: Global Industry Analysis and Forecast 2016 - 2024 Persistence Market Research Released New Market Report on “Ependymoma Market: Global Industry Analysis and Forecast 2016 - 2024”. Ependymoma are tissue-based tumors arising from the cells lining the ventricles and central canal within the spinal cord. Symptoms of ependymal tumors are related to the area within the brain and size of the tumor. Increased head size may be one of the first symptoms noted in pediatric patients. Irritability, sleeplessness, and vomiting symptoms may develop with growth of tumor. In older children and adults, nausea, vomiting, and headache, are the most common symptoms noted. According to American Brain Tumor Association, ependymomas are relatively rare tumors occurring in adults, accounting for 2-3% of primary brain tumors. However, there are the sixth most common brain tumor occurring in pediatric patients. About 30% of pediatric ependymoma are diagnosed in children younger than three years of age. Like many tumor types, the exact cause of ependymoma is not known. Unknown causes and lucrative revenue prospects have grabbed attention from big drug makers and thus the market is expected to exhibit significant growth in market value over the forecast years. The global ependymoma market could be segmented based on type of disease and treatment.
Based on type of disease,
Myxopapillary Ependymomas
Subependymomas
Classic Ependymomas
Anaplastic Ependymomas
Based on treatment type,
Radiotherapy
Surgery
Chemotherapy
Steroids
Anticonvulsants
Segmentation based on regions
Based on disease type, myxopapillary ependymomas occur primarily at the base area of spine called filum terminale. This disease is uncommon in children. Subependymomas are usually incidental tumors and are most uncommon in children. Classic ependymomas can arise anywhere in the central nervous system, but commonly develop in the posterior fossa. Anaplastic ependymomas, in general, exhibit high growth rate and currently exhibit inadequate prognosis. Most common treatments of ependymoma include surgical removal of ependymoma
Persistence Market Research
2
Ependymoma Market: Global Industry Analysis and Forecast 2016 - 2024 or by radiotherapy. Though specific medicinal therapies are not available for treating ependymoma, certain drugs can be used to treat the symptoms of disease. Chemotherapy could be used to ascertain the continuation of the metastases process. Physicians could also prescribe anticonvulsants and steroids to reduce symptoms of ependymoma. Interested in report: Please follow the below the links to meet your requirements; Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/10723 Geographically, North America dominates global ependymoma market followed by Europe due to availability of highly developed healthcare infrastructure and sophisticated treatment technologies. Asia-Pacific is expected to emerge as promising market for ependymoma due to increasing medical tourism industry, increase in purchasing power, rapidly improving healthcare infrastructure and increased awareness on overall healthcare and available treatments. Key companies operational in global ependymoma market are Eli Lilly and Company, Astellas US Holding, Inc., DNAtrix, Inc., Advantagene, Inc., Burzynski Research Institute, Inc., Direct Therapeutics,Inc., Cellectar Biosciences, Inc., and others. Request TOC (table of content), Figures http://www.persistencemarketresearch.com/toc/10723
and
Tables
of
the
Report:
The report covers exhaustive analysis on:
Ependymoma Market Segments
Ependymoma Market Dynamics
Historical Actual Market Size, 2013 - 2015
Ependymoma Market Size & Forecast 2016 to 2022
Ependymoma Current Trends/Issues/Challenges
Competition & Companies involved
Ependymoma Drivers and Restraints
Regional analysis includes
North America
Latin America
Europe
Asia Pacific
Persistence Market Research
3
Ependymoma Market: Global Industry Analysis and Forecast 2016 - 2024
Middle East & Africa
For more Info: http://www.persistencemarketresearch.com/contact-us.asp Report Highlights:
Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance
Follow us on LinkedIn: https://www.linkedin.com/company/persistence-market-research-&consulting Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc (as applicable) 2. The report covers geographic segmentation North America Europe Asia RoW 3. The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020 4. The report provides company profiles of some of the leading companies operating in the market 5. The report also provides porters five forces analysis of the market. Browse the full “All Upcoming Persistence Market's ” report at http://www.persistencemarketresearch.com/forthcoming-reports.asp About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services
Persistence Market Research
4
Ependymoma Market: Global Industry Analysis and Forecast 2016 - 2024 At Persistence Market Research (PMR), we are in the business of accelerating your business. As a full-service market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability. PMR’s Services Go Beyond Gleaning Data: Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines.
Facilitating Rapid and Informed Business Decisions PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by carefully balancing traditional and modern-day research methodologies. Contact Us: Addie Thomes 305 Broadway, 7th Floor, New York City, NY 10007, United States. Phone: +1-646-568-7751 USA/Canada Toll Free Number. 1-800-961-0353 E-mail: Sales@persistencemarketresearch.com Web : http://www.persistencemarketresearch.com/
Persistence Market Research
5